Ventiv to Deliver Glaxo Program

Share this article:
Ventiv Health Communications, New York, the former Snyder Healthcare Communications that was recently spun off into an independent public company, said this week it will create a migraine campaign for Glaxo Wellcome.


The integrated marketing program, called e.Scape Migraine, will target physicians and focus on migraine diagnosis and treatment education.


Separately, Ventiv and Snyder share prices both have performed poorly, hitting 52-week lows consistently since the September 28 spin-off occurred. Snyder Communications did not return calls seeking comment. Snyder Communications' stock price was $12.50 as of Oct. 15; Ventiv's was $7.88 the same day.
Share this article:
You must be a registered member of Direct Marketing News to post a comment.
close

Next Article in Agency

Sign up to our newsletters

Follow us on Twitter @dmnews

Latest Jobs:

More in Agency

The Mobile-Email Marriage

The Mobile-Email Marriage

Marketers who considered leaving email at the altar are finding renewed passion for the channel as an ever-increasing number of customers triage, read, and click-through email on their smartphones.

Harnessing Deep Industry Expertise to Capture New Markets

Harnessing Deep Industry Expertise to Capture New Markets

Darren Rodgers explains how he applies his deep healthcare expertise, and broad organizational experience, to marketing in an industry in the throes of historic transformation.

Fast Facts: October 2014

Fast Facts: October 2014

Some quick info hits to keep you up-to-date, including the percentage of emails opened on mobile devices.